Head-to-head · WeighScore
FitFlow vs RestorLife Med
The verdict
FitFlow takes it — 67.8/100 to 65.3/100.
FitFlow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FitFlow (FitFlow Health) is a 100% online compounded telehealth platform for GLP-1 weight loss - compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FitFlow | RestorLife Med |
|---|---|---|
| WeighScore | 67.8/100 | 65.3/100 |
| Grade | C | C |
| Scorecard rank | #155 | #222 |
| Semaglutide | $175/mo (compounded) | $199/mo (6-month plan, compounded) |
| Tirzepatide | $235/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #155 · C
Strengths
- Compounded semaglutide (=Wegovy) and tirzepatide (=Mounjaro); month-to-month from $175/$235, or as low as $99/$125 on annual prepay
- 100% online 4-step process; board-certified provider review in 24-48 hours, with unlimited messaging and dose adjustments
- Free nationwide shipping (discreet, 5-7 days) from US-licensed compounding pharmacies
- FSA/HSA eligible with financing (Affirm, Klarna, Afterpay); month-to-month or prepay plans, cancel anytime
- Transparent 'no hidden fees' pricing; 6,000+ members; same-platform add-ons (NAD+, sermorelin, MIC+B12, glutathione, hair, sexual health)
Where it loses points
- Headline '$99/$125 a month' requires a full year prepaid upfront ($1,188 / $1,500); true month-to-month is $175 / $235
- Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- The compounding pharmacy partner is not named ('US-licensed / FDA-regulated pharmacies' only)
- State-availability list is not published (free nationwide shipping advertised, but no explicit state list)
- No LegitScript certification displayed
Graded #222 · C
Strengths
- Verifiable LegitScript certification (seal ID 50400451) plus a named board-certified physician (Dr. Michael Wasef, MD) licensed in all 50 states
- Full GLP-1 lineup: compounded semaglutide and tirzepatide, plus gentler microdose entry options
- Generous support — unlimited care-team messaging, monthly check-ins, dosage adjustments, and 1 free blood test per quarter on the GLP-1 protocols
- Available in all 50 states with free priority shipping, discreet packaging, and roughly 48-hour delivery
- Transparent multi-month pricing with 50% off your first month; semaglutide protocols are compounded with B12
Where it loses points
- The advertised $299 is a struck-through anchor price, not a starting point: the real month-to-month rate is $299, a first month runs $149 at 50% off, and the $199 rate needs six months
- The page states its pricing is 'introductory and subject to change', so none of these figures is committed to
- The tirzepatide price is published the same way, against a struck-through anchor, and we could not establish which figure a buyer actually pays
- A separate semaglutide microdose is sold at $99/mo — a sub-therapeutic protocol, not a cheaper weight-loss dose
- Compounded semaglutide and tirzepatide are not FDA-approved finished products
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.